Stripe and a coalition of high-profile donors have launched a $500 million nonprofit called Intercept to develop vaccines and air-purification technologies aimed at eliminating common respiratory viruses.

Key Points

• Stripe is spearheading the $500 million initiative alongside funders including Anthropic, the OpenAI Foundation, Bill Gates, and Jane Street Capital.
• The nonprofit, named Intercept, aims to combat the more than 200 viruses that cause the common cold and flu.
• Proposed solutions include broad-spectrum vaccines and large-scale air-cleaning systems, such as ultraviolet light, for public spaces.
• The project is led by Stripe executive Nan Ransohoff and venture capitalist Charlie Petty.
• Advisors include former FDA official Peter Marks and Operation Warp Speed leader Moncef Slaoui.

Why it Matters

This initiative addresses a significant public health burden that is often overlooked by traditional pharmaceutical companies due to the high number of viral variants. By funding infrastructure and research, Intercept seeks to treat clean air as a public utility similar to municipal water systems.